三倍的可能性:多药制药增加了住院儿科患者药物治疗问题的发生率
Bereket Takele1, Hailu Chare Koyra1, Temesgen Sidamo1
1School of Pharmacy, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia.
Frontiers in pharmacology
|May 10, 2024
概括
药物治疗问题 (DTP) 在儿科患者中很常见,影响超过60%. 诸如多种疾病和多种药房等因素增加了DTP的风险,突出了改善药物护理的需要.
科学领域:
- 临床药房 临床药房
- 儿科药理学 儿科药理学
- 药品安全 药品安全
背景情况:
- 由于器官系统未成熟,儿科患者面临更高的药物治疗问题 (DTP) 风险.
- 之前的研究通常集中在单个DTP元素上,因此需要采取全面的方法.
- 这项研究评估了住院儿科患者的DTP患病率和相关因素.
研究的目的:
- 确定儿科患者中药物治疗问题 (DTP) 的患病率.
- 在这个人群中识别与DTP相关的因素.
- 为减少住院儿童DTP的策略提供信息.
主要方法:
- 一项基于机构的横截面研究在一年内进行.
- 简单的随机抽样选择了369名儿科患者.
- 使用Cipolle和Strand的分类方法,从医疗记录中识别和分类DTP.
主要成果:
- 在369名儿科患者中,DTP的总体患病率为60.2%.
- 需要额外的药物治疗是最常见的DTP (49.8%).
- 疾病数量,多药店和住院时间是DTP的重要预测因素.
结论:
- 在住院的儿科患者中存在DTP的高患病率.
- 多种疾病状况,多种药物和长时间住院是关键预测因素.
- 改善药物护理,优化剂量和减缓处方可以减少儿科DTPs.
相关概念视频
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
126
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
126
Prescription, Nonprescription and Orphan Drugs
721
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
721
Nonlinear Pharmacokinetics: Overview
354
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
354
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123


